Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Prostatic Acid Phosphatase
Email alerts
Prostatic Acid Phosphatase
Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine
Ellen
Wargowski
,
Laura E.
Johnson
,
Jens C.
Eickhoff
,
Lauren
Delmastro
,
Mary Jane
Staab
,
Glenn
Liu
,
Douglas G.
McNeel
Journal for ImmunoTherapy of Cancer
Dec 2018,
6
(1)
21;
DOI:
10.1186/s40425-018-0333-y
Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination
Laura E.
Johnson
,
Brian M.
Olson
,
Douglas G.
McNeel
Journal for ImmunoTherapy of Cancer
Dec 2017,
5
(1)
56;
DOI:
10.1186/s40425-017-0260-3
B lymphocyte mediated antigen presentation of plasmid DNA
Viswa Teja
Colluru
,
Douglas G
McNeel
Journal for ImmunoTherapy of Cancer
Nov 2013,
1
(Suppl 1)
P204;
DOI:
10.1186/2051-1426-1-S1-P204
Induction of antigen spread after sipuleucel-T treatment and its association with improved clinical outcome
Debraj
GuhaThakurta
,
Li-Qun
Fan
,
Tuyen
Vu
,
Nadeem A
Sheikh
,
James B
Trager
Journal for ImmunoTherapy of Cancer
Nov 2013,
1
(Suppl 1)
P101;
DOI:
10.1186/2051-1426-1-S1-P101
Special collections
COVID-19
(37)
Editor's choice
JITC
Basic Tumor Immunology
(386)
Case Reports
(178)
Clinical Trials Monitor
(16)
Clinical/Translational Cancer Immunotherapy
(699)
Commentary/Editorials
(114)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(36)
Guidelines and Consensus Statements
(24)
Imaging and Immunotherapy
(2)
Immune Cell Therapies and Immune Cell Engineering
(115)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(281)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(91)
Reviews
(189)
Open access
(2336)
Press releases